Literature DB >> 10358053

The Listeria monocytogenes protein InlB is an agonist of mammalian phosphoinositide 3-kinase.

K Ireton1, B Payrastre, P Cossart.   

Abstract

The Gram-positive pathogen Listeria monocytogenes induces its own internalization into some non-phagocytic mammalian cells by stimulating host tyrosine phosphorylation, phosphoinositide (PI) 3-kinase activity, and rearrangements in the actin cytoskeleton. Entry into many cultured cell lines is mediated by the bacterial protein InlB. Here we investigate the role of InlB in regulating mammalian signal transduction and cytoskeletal structure. Treatment of Vero cells with purified InlB caused rapid and transient increases in the lipid products of the PI 3-kinase p85-p110, tyrosine phosphorylation of the mammalian adaptor proteins Gab1, Cbl, and Shc, and association of these proteins with p85. InlB also stimulated large scale changes in the actin cytoskeleton (membrane ruffling), which were PI 3-kinase-dependent. These results identify InlB as the first reported non-mammalian agonist of PI 3-kinase and demonstrate similarities in the signal transduction events elicited by this bacterial protein and known agonists such as epidermal growth factor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10358053     DOI: 10.1074/jbc.274.24.17025

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways.

Authors:  J Celli; M Olivier; B B Finlay
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  Differential inlA and inlB expression and interaction with human intestinal and liver cells by Listeria monocytogenes strains of different origins.

Authors:  Hadewig Werbrouck; Koen Grijspeerdt; Nadine Botteldoorn; Els Van Pamel; Nancy Rijpens; Jo Van Damme; Mieke Uyttendaele; Lieve Herman; Els Van Coillie
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

Review 3.  Exploitation of the ubiquitin system by invading bacteria.

Authors:  Olivia Steele-Mortimer
Journal:  Traffic       Date:  2010-11-24       Impact factor: 6.215

Review 4.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

5.  Analysis of receptor tyrosine kinase internalization using flow cytometry.

Authors:  Ning Li; Kristen S Hill; Lisa A Elferink
Journal:  Methods Mol Biol       Date:  2008

6.  Quantitative phosphokinome analysis of the Met pathway activated by the invasin internalin B from Listeria monocytogenes.

Authors:  Tobias Reinl; Manfred Nimtz; Claudia Hundertmark; Thorsten Johl; György Kéri; Jürgen Wehland; Henrik Daub; Lothar Jänsch
Journal:  Mol Cell Proteomics       Date:  2009-07-29       Impact factor: 5.911

7.  SigmaB- and PrfA-dependent transcription of genes previously classified as putative constituents of the Listeria monocytogenes PrfA regulon.

Authors:  Juliane Ollinger; Martin Wiedmann; Kathryn J Boor
Journal:  Foodborne Pathog Dis       Date:  2008-06       Impact factor: 3.171

8.  Listeria monocytogenes antagonizes the human GTPase Cdc42 to promote bacterial spread.

Authors:  Luciano A Rigano; Georgina C Dowd; Yi Wang; Keith Ireton
Journal:  Cell Microbiol       Date:  2014-01-24       Impact factor: 3.715

Review 9.  Effects of Curcumin and Its Analogues on Infectious Diseases.

Authors:  Reza Ranjbar; Hossein Bagheri; Faezeh Ghasemi; Paul C Guest; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Met receptor tyrosine kinase degradation is altered in response to the leucine-rich repeat of the Listeria invasion protein internalin B.

Authors:  Xiu Gao; Marta Lorinczi; Kristen S Hill; Natasha C Brooks; Hatem Dokainish; Keith Ireton; Lisa A Elferink
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.